Literature DB >> 18796520

Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism.

L Damaj1, M le Lorch, V Verkarre, C Werl, L Hubert, C Nihoul-Fékété, Y Aigrain, Y de Keyzer, S P Romana, C Bellanne-Chantelot, P de Lonlay, F Jaubert.   

Abstract

CONTEXT: Focal forms of congenital hyperinsulinism are due to a constitutional heterozygous mutation of paternal origin in the ABCC8 gene, more often than the KCNJ11 gene, located in the 11p15.1 region. This mutation is associated with the loss of the maternally inherited 11p15.1 to 11p15.5 region in the lesion. We investigated the possible occurrence of a compensatory duplication of the paternal 11p15.1-11p15.5 region.
MATERIALS AND METHODS: A combined immunohistochemistry and fluorescent in situ hybridization study on beta-cell interphase nuclei with probes covering two genes located in this region (ABCC8 and CDKN1C genes) was performed in four cases of focal forms of hyperinsulinism.
RESULTS: beta-Cells in the lesions of four cases of focal congenital hyperinsulinism were diploid for chromosomes 11 and 13. The 11p15.1 to 11p15.2 and 11p15.4 to 11p15.5 regions containing ABCC8 and CDKN1C genes, respectively, were present with two copies. Loss of the maternal allele was confirmed in these focal lesions with microsatellite markers flanking the ABCC8 and CDKN1C genes, whereas a heterozygous mutation in the ABCC8 gene was inherited from the father.
CONCLUSIONS: There is a duplication of the paternal allele on chromosome 11 in the focal forms of hyperinsulinism lesion. The paternal isodisomy observed rendered the beta-cells homozygous for ABCC8 mutation and harbored a K-channel defect in the lesion similar to that observed in diffuse forms of congenital hyperinsulinism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796520     DOI: 10.1210/jc.2008-0673

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.

Authors:  Dunia Ismail; Khalid Hussain
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

Review 2.  Pancreatic β-cell KATP channels: Hypoglycaemia and hyperglycaemia.

Authors:  Kate Bennett; Chela James; Khalid Hussain
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

3.  In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.

Authors:  Jean-Claude Henquin; Myriam Nenquin; Christine Sempoux; Yves Guiot; Christine Bellanné-Chantelot; Timo Otonkoski; Pascale de Lonlay; Claire Nihoul-Fékété; Jacques Rahier
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

4.  Focal congenital hyperinsulinism in a patient with septo-optic dysplasia.

Authors:  Raja Padidela; Ritika R Kapoor; Yuva Moyo; Clare Gilbert; Sarah E Flanagan; Sian Ellard; Khalid Hussain
Journal:  Nat Rev Endocrinol       Date:  2010-09-14       Impact factor: 43.330

5.  The heterogeneity of focal forms of congenital hyperinsulinism.

Authors:  Dunia Ismail; Ritika R Kapoor; Virpi V Smith; Michael Ashworth; Oliver Blankenstein; Agostino Pierro; Sarah E Flanagan; Sian Ellard; Khalid Hussain
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

6.  Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation.

Authors:  Sarah E Flanagan; Weijia Xie; Richard Caswell; Annet Damhuis; Christine Vianey-Saban; Teoman Akcay; Feyza Darendeliler; Firdevs Bas; Ayla Guven; Zeynep Siklar; Gonul Ocal; Merih Berberoglu; Nuala Murphy; Maureen O'Sullivan; Andrew Green; Peter E Clayton; Indraneel Banerjee; Peter T Clayton; Khalid Hussain; Michael N Weedon; Sian Ellard
Journal:  Am J Hum Genet       Date:  2012-12-27       Impact factor: 11.025

7.  Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells.

Authors:  Jean-Claude Henquin; Christine Sempoux; Joelle Marchandise; Sebastien Godecharles; Yves Guiot; Myriam Nenquin; Jacques Rahier
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

Review 8.  Congenital hyperinsulinism: current trends in diagnosis and therapy.

Authors:  Jean-Baptiste Arnoux; Virginie Verkarre; Cécile Saint-Martin; Françoise Montravers; Anaïs Brassier; Vassili Valayannopoulos; Francis Brunelle; Jean-Christophe Fournet; Jean-Jacques Robert; Yves Aigrain; Christine Bellanné-Chantelot; Pascale de Lonlay
Journal:  Orphanet J Rare Dis       Date:  2011-10-03       Impact factor: 4.123

9.  Familial focal congenital hyperinsulinism.

Authors:  Dunia Ismail; Virpi V Smith; Pascale de Lonlay; Maria-Joao Ribeiro; Jacques Rahier; Oliver Blankenstein; Sarah E Flanagan; Christine Bellanné-Chantelot; Virginie Verkarre; Yves Aigrain; Agostino Pierro; Sian Ellard; Khalid Hussain
Journal:  J Clin Endocrinol Metab       Date:  2010-10-13       Impact factor: 5.958

10.  Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.

Authors:  S E Flanagan; R R Kapoor; I Banerjee; C Hall; V V Smith; K Hussain; S Ellard
Journal:  Clin Genet       Date:  2011-06       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.